GAMMA Investing’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Other funds holding TNXP
JHC
GAMMA Investing's TNXP Position: Q3 2026 in Review
GAMMA Investing reduced its Tonix Pharmaceuticals (TNXP) stake by 13% in Q3 2026, selling an estimated $425 and leaving 252 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3887.
GAMMA Investing first reported a position in TNXP in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.9K in Q1 2026. 113 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.
- GAMMA Investing held 252 shares of Tonix Pharmaceuticals worth $2.45K as of Q3 2026.
- GAMMA Investing sold 36 Tonix Pharmaceuticals shares in Q3 2026, an estimated $425.
- Tonix Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3887 holding.
- GAMMA Investing first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- GAMMA Investing's Tonix Pharmaceuticals position peaked at $3.9K in Q1 2026.
- 113 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.